Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Zoledronic Acid Infusion in the Bone Loss Observed Following Denosumab Discontinuation in Postmenopausal Women With Low Bone Mass

NCT02499237 is registered in ClinicalTrials.gov with 424 General Military Hospital as lead sponsor.

NCT NCT02499237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02499237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Zoledronic Acid Infusion in the Bone Loss Observed Following Denosumab Discontinuation in Postmenopausal Women With Low Bone Mass
Lead sponsor
424 General Military Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2015
Completion date
November 26, 2018
Enrollment
57 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis